Starbridge

Discover opportunities months before the RFP drops

Learn more →
Shyam Patel - verified email & phone - Associate Vice President of Preclinical Development at California Institute for Regenerative Medicine (CA) | Gov Contact | Starbridge | Starbridge
Buyers/California Institute for Regenerative Medicine/Shyam Patel
SP

Shyam Patel

Verified

Associate Vice President of Preclinical Development

Work Email

s*****@c**********

Direct Phone

+1 (***) ***-****
OverviewOrganizationMentionsColleagues

Employing Organization

California Institute for Regenerative Medicine

CA

Meeting Mentions

Board meetings and strategic plans from Shyam Patel's organization

Jan 1, 2026·Strategic Plan

Concept Plan 2026-2027

Strategic

The Data Science and Software Engineering (INFR9) Concept Plan outlines a strategy to accelerate regenerative medicine research through the development of innovative, open source software for data integration. Key priorities include supporting the creation of broadly applicable, validated tools to solve multimodal data integration bottlenecks in stem cell-based and genetic therapy research. The plan emphasizes robust deployment, adoption, and sustainability, adherence to open source best practices and transparent development, fostering community and contributor engagement, and utilizing pre-existing public datasets. This initiative is designed to catalyze the identification and validation of novel targets and biomarkers and reduce time to therapeutic development.

May 8, 2026·Board Meeting

Access and Affordability Working Group of the Independent Citizens' Oversight Committee Regular Meeting

Board

The meeting focused on informational updates regarding access and affordability for cell and gene therapies. Key topics included a recap of an Access and Affordability Summit, an FDA workshop on pediatric clinical trials, an update on the first CIRM-funded gene therapy approval for Leuko-cyte Adhesion Deficiency 1, and revisions to access plan requirements for preclinical and clinical programs.

May 9, 2026·Board Meeting

Cirm Aawg Meeting

Board

The meeting focused on informational updates regarding the broader engagement of the patient access team and the organization of the AWG's strategy for cell and gene therapy access and affordability. Key topics included a recap of a collaborative summit with ISSCR and UCLA on therapy accessibility and payment models, as well as an FDA workshop discussing the design of pediatric rare disease clinical trials and the importance of including parent and patient advocate input in trial design and execution.

Mar 26, 2026·Board Meeting

Independent Citizens' Oversight Committee Regular Meeting

Board

The committee meeting focused on several key items, including the appointment and reappointment of scientific members to the Grants Working Group, as well as the evaluation procedures for committee leadership and the CIRM President/CEO. Discussions also covered amendments to funding mechanisms for CIRM conferences and meetings. A major portion of the session was dedicated to the consideration of applications for discovery program announcements and clinical program announcements, along with amendments to the Community Cares Centers of Excellence concept plan. The committee reviewed program preferences, guiding principles, and a co-funding program amendment. Additionally, the committee received updates from the communications team and reports from the Chair and President.

Mar 9, 2026·Board Meeting

Governance Subcommittee Governance Subcommittee Meeting

Board

The meeting focused on the annual review process for executive evaluations, specifically outlining adjustments to the timeline, new survey questions, the inclusion of a merit increase recommendation, and the requirement for leadership to set meaningful goals for the upcoming year. The subcommittee approved the proposed timeline and survey instruments for presentation to the full board.

Premium
More meetings available

Extracted from official board minutes, strategic plans, and video transcripts.

Key Colleagues

Decision makers at California Institute for Regenerative Medicine

View All
Enterprise

Get verified contact data at scale

Enrich your entire CRM with verified emails, phone numbers, and buyer intelligence for every account in your TAM.

Verified emails & phones
Batch enrichment for TAM
Account-level scoring

CRM Sync

Keep data fresh automatically

Salesforce & HubSpot
Real-time updates
Custom field mapping

Bulk Account Enrichment

What makes us different

Account-level scoring
Batch enrichment for TAM
Prioritize accounts
Features
Buying Signal MonitorContacts & Company DataPublic Spend IntelligenceAI RFP Finder & Proposal Writer
Popular Use Cases
Automate deep account researchKeep contact data up-to-date in your CRMOutbound based on upcoming competitor expirations
C
★

Claudette Mandac

Associate Director, Board Governance

B
★

Ben Chau

Associate Director of Information Technology

V

Vito Imbasciani

Chair, Independent Citizens’ Oversight Committee (ICOC) — CIRM Governing Board Chair

R
★

Rosa Maria Canet-Avilés

Chief Science Officer

Key decision makers in the same organization

Salesforce & HubSpot sync
Learn More →
Integrations
SalesforceHubSpot
Resources
Research & ReportsGrowth Tools & PlaybooksBlogCustomer StoriesRFP CatalogGovernment Buyers
About
About UsCareers
Terms & Privacy
PrivacyTerms

© 2026 Starbridge